An observational study in Heart Failure, sponsored by Spectrum Health Hospitals. Terminated at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-06-05.
Sponsored by Spectrum Health Hospitals · Observational
This study is meant to predict the outcome of VAD therapy, by forming a VAD registry for quality assessment, research, and real-time monitoring of patients on VAD therapy. The goal is to optimize the use of VAD therapy for patients, to create an online quality measurement tool for VAD treatment, and to create algorithms to estimate the prognosis for patients getting a VAD.
Patients eligible for VAD are being sampled before surgery for plasma as well as peripheral blood cells. After surgery patients are being sampled again at 24 h and 7 days. Inflammatory response is being monitored on gene expression as well as cell level and on cytokine level in relation to the outcome.
5,701 studies on the registry are indexed under Heart Failure; 1,220 are open to participants now.
This study's enrollment of 371 is above the median of 200 across 1,679 observational studies indexed under Heart Failure.
Browse Heart Failure studies →Spectrum Health Hospitals is the lead sponsor of 38 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients being implanted with a ventricular assist device.
Exclusion Criteria:
One year mortality
Mortality will be assessed yearly.
Time frame: One year
Cytokine Analysis
Time frame: Pre-implant, within 24 hours of implant, and 7 days post-implant
Inflammatory cell subtype
Time frame: Pre-implant, within 24 hours of implant, and 7 days post-implant
Hospital readmissions
Time frame: Will be assessed yearly until death or explant
Plan to share: No
No publications or documents are linked to this record.
This study is terminated, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Spectrum Health Hospitals